期刊文献+

抑癌基因MTUS1在结直肠癌的表达与其淋巴结转移呈负相关 被引量:1

Expression of Tumor Suppressor Gene MTUS1 has Significant Negative Correlation with Lymph Node Metastasis in Colorectal Cancer
原文传递
导出
摘要 微管相关肿瘤抑制基因1(MTUS1)是一个新的肿瘤抑制基因,编码血管紧张素II AT受体结合蛋白(ATIPs).MTUS1基因表达下调可促进肿瘤细胞增殖,但MTUS1基因表达在结直肠癌转移中的作用尚不知晓.本文以接受根治性手术、经病理检查证实的50例结直肠癌患者新鲜癌组织、癌旁组织和远癌组织为材料,探索MTUS1基因表达与结直肠癌淋巴结转移的关系.荧光定量PCR及蛋白质免疫印迹揭示,有淋巴结转移的结直肠癌患者的癌及癌旁组织MTUS1基因表达的mRNA及蛋白质水平明显低于无淋巴结转移的患者.MTUS1蛋白质在淋巴结转移的结直肠癌患者的癌及癌旁组织表达下调,并进一步得到免疫组织化学的验证.实验结果提示,MTUS1的表达量与肿瘤的侵润深度有明显的负相关性.结合临床资料,推断抑癌基因MTUS1在肿瘤的发生、发展及淋巴转移中发挥重要作用. Microtubule associated tumor suppressor 1 (MTUS1) as a new tumor suppressor gene codes for angiotensin II AT2 receptor interacting protein (ATIPs). Although the down-regulation of MTUS1 promotes tumor cell proliferation, the affection of the expression of MTUS1 in colorectal cancer metastasis was unknown. We collected the 50 cases of CRC patients who received radical resection confirmed by pathology at three positions (cancer tissues, paracancer tissues and normal distal tissues) for studying the correlation between the expression of MTUS1 and the lymph node metastasis in colorectal cancer. With fluorescence quantitative PCR (qRT-PCR), Western blot and immunocytochemistry staining, we found that the expression level of MTUS1 mRNA and protein in carcinoma tissues and adjacent noncancerous tissues was significantly lower in the cases with the lymph node metastatic CRC patients than those of the patients without lymph node metastasis (P 〈 0.05). Combining with clinical data, our study indicated that the tumor suppressor gene MTUS1 might play an important role in tumor lymph metastasis.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2013年第12期1153-1158,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 重庆市科技攻关项目(No.cstc2012gg-yyjs0644) 吴阶平基金项目(No.320.6750.12685)~~
关键词 结直肠癌 微管相关肿瘤抑制基因1 肿瘤抑制 转移 colorectal cancer microtubule associated tumor suppressor 1 gene (MTUS1) tumor suppressor metastasis
  • 相关文献

参考文献27

  • 1Jemal A , Siegel R, Ward E,et al. Cancer statistics. 2009 [ J ].CA Cancer J Clin, 2009, 59(4) : 225-249.
  • 2Geiger T R, Peeper D S. Metastasis mechanisms [ J ]. BiochimBiophys Acta, 2009,1796 (2) : 293- 308.
  • 3Ramaswamy S, Ross K N,Lander E S, ef al. A molecularsignature of metastasis in primary solid tumors [ J ]. Nat Genet,2003, 33(1) :49-54.
  • 4Seibold S, Rudroff C,Weber M,et al. Identification of a newtumor suppressor gene located at chromosome 8p21. 3-22 [J].FASEB J, 2003,17(9) : 1180-1182.
  • 5Di Benedetto M,Bifeche I,Deshayes F,et al. Structuralorganization and expression of human MTUS1,a candidate 8p22tumor suppressor gene encoding a family of angiotensin II AT2receptor-interacting proteins,ATIP [ J]. Gene,2006,380 (2):127-136.
  • 6Bacolod M D, Barany F. Gene dysregulations driven by somaticcopy number aberrations- biological and clinical implications incolon tumors : a paper from the 2009 William Beaumont HospitalSymposium on Molecular Pathology [ J ]. J Mol Diagn, 2010,12(5): 552-561.
  • 7Louis S N, Chow L, Rezmann L, et al. Expression and functionof ATIP/MTUS1 in human prostate cancer cell lines [ J ].Prostate, 2010,70(14) : 1563-1574.
  • 8Ye H,Pungpravat N,Huang B L, ef al. Genomic assessments ofthe frequent loss of heterozygosity region on 8p21. 3-p22 in headand neck squamous cell carcinoma[ J]. Cancer Genet Cytogenet,2007,176(2) : 100-106.
  • 9Molina A, Velot L, Ghouinem L, et al. ATIP3, a novelprognostic marker of breast cancer patient survival,limits cancercell migration and slows metastatic progression by regulatingmicrotubule dynamics [ J ]. Cancer Res, 2013,73 ( 9 ) : 2905-2915.
  • 10Conlin A, Smith G, Carey F A, ef al. The prognostic significanceof K-ras, p53 , and APC mutations in colorectal carcinoma [ J ].Gut, 2005, 54(9) : 1283-1286.

二级参考文献34

  • 1Hida T,Ogawa S,Park J C,et al.Gefitinib for the treatment of non-small-cell lung cancer[J].Expert Rev Anticancer Ther,2009,9(1):17-35.
  • 2Boysen M,Longson C,Stevens A.Erlotinib for the treatment of non-small-cell lung cancer[J].Lancet Oncol,2009,10(1):15-16.
  • 3Dragovich T,McCoy S,Fenoglio-Preiser C M,et al.PhaseⅡtrial oferlotinib in gastroesophageal junction and gastric adenocarcinomas:SWOG 0127[J].J Clin Oncol,2006,24(30):4922-4927.
  • 4Guan J L.Integrin signaling through FAK in the regulation of mammarystem cells and breast cancer[J].IUBMB Life,2010,62(4):268-276.
  • 5Yun S P,Ryu J M,Han H J.Involvement ofβ1-integrin via PIP com-plex and FAK/paxillin in dexamethasone-induced human mesenchymalstem cells migration[J].J Cell Physiol,2011,226(3):683-692.
  • 6Li D,Ding J,Wang X,et al.Fibronectin promotes tyrosine phospho-rylation of paxillin and cell invasiveness in the gastric cancer cell lineAGS[J].Tumori,2009,95(6):769-779.
  • 7Kim S H,Kim S H.Antagonistic effect of EGF on FAK phosphoryla-tion/dephosphorylation in a cell[J].Cell Biochem Funct,2008,26(5):539-547.
  • 8Ricono J M,Huang M,Barnes L A,et al.Specific cross-talk betweenepidermal growth factor receptor and integrin alphavbeta5 promotes car-cinoma cell invasion and metastasis[J].Cancer Res,2009,69(4):1383-1391.
  • 9Bessette D, Qiu D, Pallen C. PRL PTPs: mediators and markersof cancer progression [ J ]. Cancer Metastasis Rev,2008 , 27(2):231-252.
  • 10Peng L,Xing X, Li W, et al. PRL-3 promotes the motility,invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin betal-ERKl/2 and~MMP2 signaling [ J]. Mol Cancer,2009, 8:110.

共引文献8

同被引文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部